Found 29 matching trials
Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy PHASE2 The purpose of the proposed study is to provide a clinical approach to chem...
Show More Learn More & Join Trial
A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy EARLY_PHASE1 This is a single-site, open-label, randomized pilot feasibility study condu...
Show More Location
Ottawa Hospital Cancer Centre
Learn More & Join Trial
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting PHASE3 NETU-10-29 is a clinical study assessing safety of netupitant and palonoset...
Show More Location
Northwest Alabama Cancer Center PC
Learn More & Join Trial
A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients PHASE4 This study was a multicenter, prospective, controlled trial involving 120 b...
Show More Location
Multiple Locations
Learn More & Join Trial
NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd N/A This clinical trial is a prospective, observational, multicenter cohort stu...
Show More Status
Enrolling By Invitation
Location
Samsung Medical Center
Learn More & Join Trial
Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV PHASE2 Prevention and control of Chemotherapy-Induced Nausea and Vomiting (CINV) a...
Show More Location
Multiple Locations
Learn More & Join Trial
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk) PHASE4 MyRisk: Efficacy and safety evaluation of oral Akynzeo® in patients receivi...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients PHASE4 This pragmatic trial addresses the clinical gap through the generation of e...
Show More Learn More & Join Trial
Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant PHASE2 This phase II trial studies how well netupitant and palonosetron hydrochlor...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin PHASE3 This study evaluates the possibility to reduce the total dose of dexamethas...
Show More Location
ASST Bergamo Ovest - Ospedale di Teviglio
Learn More & Join Trial